Verve Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Verve Therapeutics announces its annual meeting of stockholders to be held on June 5, 2025, with key proposals including the election of directors and ratification of the accounting firm.
Verve Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 5, 2025, to vote on director elections, auditor ratification, executive compensation, and other business.
Verve Therapeutics will hold its annual meeting of stockholders on June 6, 2024, to elect directors, ratify the appointment of Ernst & Young LLP, and vote on executive compensation.
Verve Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, to vote on director elections, auditor ratification, executive compensation, and other matters.